This topic contains a solution. Click here to go to the answer

Author Question: The session in which research subjects are fully informed of the research purposes and provided a ... (Read 76 times)

luvbio

  • Hero Member
  • *****
  • Posts: 623
The session in which research subjects are fully informed of the research purposes and provided a chance to ask any question that they may have about the experiment is called a(n) ____.
 a. wrap-up session
  b. post-hoc session
  c. debriefing session
  d. placebo session

Question 2

Jerome is ranking the desirability of segments. Which of the following marketing activities is he performing?
 a. segmentation
  b. targeting
  c. positioning
  d. collaborating



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Athena23

  • Sr. Member
  • ****
  • Posts: 305
Answer to Question 1

C

Answer to Question 2

b




luvbio

  • Member
  • Posts: 623
Reply 2 on: Jun 28, 2018
Wow, this really help


Jossy

  • Member
  • Posts: 336
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Liver spots have nothing whatsoever to do with the liver. They are a type of freckles commonly seen in older adults who have been out in the sun without sufficient sunscreen.

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library